Sellogen DFL
169799-82-0
|
Cefquinome
84957-30-2
|
Cefpirome sulfate
98753-19-6
|
SK 28501
7799-33-9
|
sephacryl(r) s-300-hr, for chromato- graphy*
82785-74-8
|
Mast Cell Degranulating (MCD) Peptide HR-1
80533-94-4
|
Mast Cell Degranulating (MCD) Peptide HR-2
80388-04-1
|
Glenvastatin
122254-45-9
|
Cefquinome sulfate
123766-80-3
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
2-{[5-(furan-2-yl)-4-(1H-pyrrol-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(4-phenoxyphenyl)acetamide
886941-35-1
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
N-(2-(furan-2-yl)-2-(indolin-1-yl)ethyl)cyclopropanecarboxamide
898458-10-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
(5-Phenylisoxazol-3-yl)methyl 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxylate
953013-68-8
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
